SB
SLXP

Suntrust Banks’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Suntrust Banks’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,614
Closed -$278K – 1302
2015
Q1 		$278K Sell
1,614
-507
-24% -$74.4K ﹤0.01% 1061
2014
Q4 		$243K Sell
2,121
-133
-6% -$16.1K ﹤0.01% 1077
2014
Q3 		$351K Buy
2,254
+333
+17% +$48.3K ﹤0.01% 1097
2014
Q2 		$236K Sell
1,921
-9,162
-83% -$1.01M ﹤0.01% 1305
2014
Q1 		$1.15M Sell
11,083
-166
-1% -$17K ﹤0.01% 898
2013
Q4 		$1.01M Sell
11,249
-273
-2% -$21.8K ﹤0.01% 920
2013
Q3 		$769K Buy
11,522
+8,324
+260% +$574K ﹤0.01% 1028
2013
Q2 		$211K Buy
+3,198
New +$183K ﹤0.01% 1566

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Suntrust Banks's SLXP Position: Q2 2015 in Review

Suntrust Banks sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,614 shares — an estimated $278K sold.

Suntrust Banks first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $1.15M in Q1 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Suntrust Banks reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Suntrust Banks sold 1,614 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $278K.
  • Suntrust Banks first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Suntrust Banks's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.15M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Suntrust Banks's 13F filing for Q2 2015, filed 10 Aug 2015.